Canada’s chief public health officer Dr. Theresa Tam discussed on Tuesday the processes that will be taken by Canadian health regulators after reports emerged of extremely rare blood clotting in some people who received the Johnson & Johnson COVID-19 vaccine in the United States. Johnson & Johnson has said it was aware of the rare reports of blood clots and was working with regulators to assess the data and provide relevant information.
Canada
Tam discusses process for Canadian health regulators following Johnson & Johnson COVID-19 vaccine reports
More Videos
-
Soup mix recalled after insects found in some packages
-
Poilievre demands to know if Carney saw anti-tariff ad before it aired in US
-
Health Canada approves early Alzheimer’s drug
-
All-Canadian cast of ‘& Juliet’ begin rehearsals in Toronto
-
‘What is the hold up?’: Conservatives push for bill to reduce intimate partner violence
-
Health Matters: Rising measles cases being fueled in part by vaccine hesitancy around the world, study shows
You are viewing an Accelerated Mobile Webpage.
View Original Article